Rational design of potent sialidase-based inhibitors of influenza virus replication.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8502295.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two potent inhibitors based on the crystal structure of influenza virus sialidase have been designed. These compounds are effective inhibitors not only of the enzyme, but also of the virus in cell culture and in animal models. The results provide an example of the power of rational, computer-assisted drug design, as well as indicating significant progress in the development of a new therapeutic or prophylactic treatment for influenza infection.
Medical subject headings
- Antiviral Agents
- Drug Design
- Influenza A virus
- Influenza, Human
- Neuraminidase
- Sialic Acids